专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 实用新型

TWM479001U 植物種植器失效
简体标题：植物种植器
公开(公告)号：TWM479001U
公开(公告)日：2014-06-01
申请号：TW103201748
申请日：2014-01-28
申请人：高建元 , KAO, CHIEN YUAN , 沈高男 , SHEN, GAO NAN , 楊熙宏 , YANG, HIS HUNG
发明人：高建元 , KAO, CHIEN YUAN , 沈高男 , SHEN, GAO NAN , 楊熙宏 , YANG, HIS HUNG , 林雅莉 , LIN, YA LI , 林芷宇 , LIN, CHIH YU , 錡虹汝 , CHI, HUNG JU
IPC分类号： A01C7/02

2. 发明授权

US08461143B2 Stabilizing compositions for antibiotics and methods of use 失效
标题翻译：抗生素的稳定组合物和使用方法
公开(公告)号：US08461143B2
公开(公告)日：2013-06-11
申请号：US13299829
申请日：2011-11-18
申请人： Shen Gao , Daniel A. Moros , Satish Asotra
发明人： Shen Gao , Daniel A. Moros , Satish Asotra
IPC分类号： A61K31/43 , A61K45/06
CPC分类号： A61K31/43 , A61K9/0095 , A61K31/424 , A61K45/06 , A61K2300/00
摘要： The present invention is directed to improved liquid antibiotic formulations. In some embodiments, the present invention is directed to a composition comprising an antibiotic in a liquid comprising triglycerides, wherein the composition has less than about 5% water (w/v).
摘要翻译：本发明涉及改进的液体抗生素制剂。在一些实施方案中，本发明涉及包含含有甘油三酸酯的液体中的抗生素的组合物，其中所述组合物具有小于约5％的水（w / v）。

3. 发明授权

US08461139B2 Oral suspension of prednisolone acetate 有权
标题翻译：醋酸泼尼松龙口服悬液
公开(公告)号：US08461139B2
公开(公告)日：2013-06-11
申请号：US13483273
申请日：2012-05-30
申请人： Satish Asotra , Shen Gao , Avraham Yacobi
发明人： Satish Asotra , Shen Gao , Avraham Yacobi
IPC分类号： A61K31/537 , A61P5/00 , A61P29/00 , A61P17/00 , A61P25/00 , A61P1/00 , A61P7/00 , A61P35/00 , A61P7/10 , A61P37/08 , C07J5/00
CPC分类号： A61K9/0053 , A61K9/0095 , A61K9/10 , A61K31/57
摘要： The present invention relates to novel oral suspension formulation comprising prednisolone acetate, a pharmaceutically acceptable vehicle and a thickening agent. The present invention further provides a method of treating patients in need of prednisolone with the novel formulation.
摘要翻译：本发明涉及包含醋酸泼尼松龙，药学上可接受的载体和增稠剂的新型口服悬浮液制剂。本发明还提供了一种用新型制剂治疗需要泼尼松龙的患者的方法。

4. 发明申请

US20120028405A1 METHOD AND MATERIAL FOR PROCESSING IRON DISILICIDE FOR PHOTOVOLTAIC APPLICATION 失效
标题翻译：用于光伏应用的加工铁氰化物的方法和材料
公开(公告)号：US20120028405A1
公开(公告)日：2012-02-02
申请号：US13267239
申请日：2011-10-06
申请人： Howard W.H. Lee , Frederic Victor Mikulec , Bing Shen Gao , Jinman Huang
发明人： Howard W.H. Lee , Frederic Victor Mikulec , Bing Shen Gao , Jinman Huang
IPC分类号： H01L31/0264
CPC分类号： H01L31/0384 , C01B33/06 , C23C24/08 , C23C26/00 , H01L31/032
摘要： A method for providing a semiconductor material for photovoltaic devices, the method includes providing a sample of iron disilicide comprising approximately 90 percent or greater of a beta phase entity. The sample of iron disilicide is characterized by a substantially uniform first particle size ranging from about 1 micron to about 10 microns. The method includes combining the sample of iron disilicide and a binding material to form a mixture of material. The method includes providing a substrate member including a surface region and deposits the mixture of material overlying the surface region of the substrate. In a specific embodiment, the mixture of material is subjected to a post-deposition process such as a curing process to form a thickness of material comprising the sample of iron disilicide overlying the substrate member. In a specific embodiment, the thickness of material is characterized by a thickness of about the first particle size.
摘要翻译：一种用于提供用于光伏器件的半导体材料的方法，所述方法包括提供包含大约90％或更大的β相实体的二硅化铁样品。二硅化铁的样品的特征在于约1微米至约10微米的基本均匀的第一粒度。该方法包括将二硅化铁样品与结合材料组合以形成材料的混合物。该方法包括提供包括表面区域的衬底构件并沉积覆盖衬底的表面区域的材料混合物。在具体实施方案中，材料的混合物经历诸如固化过程的后沉积工艺，以形成包含覆盖在基底构件上的二硅化铁样品的材料的厚度。在具体实施例中，材料的厚度的特征在于约为第一粒度的厚度。

5. 发明申请

US20090048268A1 ANTI-HISTAMINE COMPOSITIONS AND USE THEREOF 有权
标题翻译：抗组胺组合物及其用途
公开(公告)号：US20090048268A1
公开(公告)日：2009-02-19
申请号：US12162171
申请日：2007-01-25
申请人： Satish Asotra , Jerzy Zadykowicz , Kalpana Vanam , Shen Gao
发明人： Satish Asotra , Jerzy Zadykowicz , Kalpana Vanam , Shen Gao
IPC分类号： A61K31/495
CPC分类号： A61K31/495 , A61K9/0095
摘要： The present invention provides for a storage stable pharmaceutical liquid solution for oral administration having a pharmaceutically effective amount of an antihistamine and having a purity equal to or greater than about 99% by weight-based HPLC assay, residual solvents of less than about 0.5%, and a total impurity of less than about 0.2%. The storage stable solution preferably contains cetirizine. The present invention further provides a process of preparing the storage stable pharmaceutical liquid solution as well as a method of treating a mammal with a therapeutically effective amount of cetirizine in the stable pharmaceutical liquid solution.
摘要翻译：本发明提供了用于口服给药的储存稳定的药物液体溶液，其具有药学有效量的抗组胺剂，并且具有等于或大于约99重量％的HPLC测定的纯度，小于约0.5％的残留溶剂，并且总杂质小于约0.2％。储存稳定溶液优选含有西替利嗪。本发明还提供了制备储存稳定的药物液体溶液的方法以及在稳定的药物液体溶液中用治疗有效量的西替利嗪治疗哺乳动物的方法。

6. 发明申请

US20070031459A1 ORAL SUSPENSION OF PREDNISOLONE ACETATE 有权
标题翻译：醋酸丙酸盐的口服悬浮液
公开(公告)号：US20070031459A1
公开(公告)日：2007-02-08
申请号：US11457197
申请日：2006-07-13
申请人： Satish Asotra , Shen Gao , Avraham Yacobi
发明人： Satish Asotra , Shen Gao , Avraham Yacobi
IPC分类号： A61K31/57 , A61K9/00 , A61K9/14
CPC分类号： A61K9/0053 , A61K9/0095 , A61K9/10 , A61K31/57
摘要： The present invention relates to novel oral suspension formulation comprising prednisolone acetate, a pharmaceutically acceptable vehicle and a thickening agent. The present invention further provides a method of treating patients in need of prednisolone with the novel formulation.
摘要翻译：本发明涉及包含醋酸泼尼松龙，药学上可接受的载体和增稠剂的新型口服悬浮液制剂。本发明还提供了一种用新型制剂治疗需要泼尼松龙的患者的方法。

7. 发明申请

US20050143471A1 Taste masking spill-resistant formulation 审中-公开
标题翻译：味道掩护防溢剂
公开(公告)号：US20050143471A1
公开(公告)日：2005-06-30
申请号：US11007903
申请日：2004-12-09
申请人： Shen Gao , Maxine Moldenhauer , Daniel Moros
发明人： Shen Gao , Maxine Moldenhauer , Daniel Moros
IPC分类号： A61K9/00 , A61K47/10 , A61K47/32 , A61K31/137
CPC分类号： A61K9/0056 , A61K9/0095 , A61K47/10 , A61K47/32
摘要： The invention relates to a spill-resistant pharmaceutical composition, comprising a spill-resistant formulation with taste masking concentrations of polyethylene glycol (PEG) and diphenhydramine, which is less bitter, sweeter and has better overall flavor than current pharmaceutical compositions, while maintaining advantageous spill-resistant properties.
摘要翻译：本发明涉及一种防溢药物组合物，其包含具有掩蔽浓度的聚乙二醇（PEG）和苯海拉明的防溢剂制剂，其比目前的药物组合物更苦，更甜，并且具有更好的总体风味，同时保持有利的溢出耐性。

8. 发明授权

US08569278B2 Anti-histamine compositions and use thereof 有权
标题翻译：抗组胺组合物及其用途
公开(公告)号：US08569278B2
公开(公告)日：2013-10-29
申请号：US12162171
申请日：2007-01-25
申请人： Satish Asotra , Jerzy Zadykowicz , Kalpana Vanam , Shen Gao
发明人： Satish Asotra , Jerzy Zadykowicz , Kalpana Vanam , Shen Gao
IPC分类号： A01N43/00 , A61K31/33
CPC分类号： A61K31/495 , A61K9/0095
摘要： The present invention provides for a storage stable pharmaceutical liquid solution for oral administration having a pharmaceutically effective amount of an antihistamine and having a purity equal to or greater than about 99% by weight-based HPLC assay, residual solvents of less than about 0.5%, and a total impurity of less than about 0.2%. The storage stable solution preferably contains cetirizine. The present invention further provides a process of preparing the storage stable pharmaceutical liquid solution as well as a method of treating a mammal with a therapeutically effective amount of cetirizine in the stable pharmaceutical liquid solution.
摘要翻译：本发明提供了用于口服给药的储存稳定的药物液体溶液，其具有药学有效量的抗组胺剂，并且具有等于或大于约99重量％的HPLC测定的纯度，小于约0.5％的残留溶剂，并且总杂质小于约0.2％。储存稳定溶液优选含有西替利嗪。本发明还提供了制备储存稳定的药物液体溶液的方法以及在稳定的药物液体溶液中用治疗有效量的西替利嗪治疗哺乳动物的方法。

9. 发明授权

US07799331B2 Oral suspension of prednisolone acetate 有权
标题翻译：醋酸泼尼松龙口服悬液
公开(公告)号：US07799331B2
公开(公告)日：2010-09-21
申请号：US11457197
申请日：2006-07-13
申请人： Satish Asotra , Shen Gao , Avraham Yacobi
发明人： Satish Asotra , Shen Gao , Avraham Yacobi
IPC分类号： A61K31/57 , A61K9/00 , A61K9/14
CPC分类号： A61K9/0053 , A61K9/0095 , A61K9/10 , A61K31/57
摘要： The present invention relates to novel oral suspension formulation comprising prednisolone acetate, a pharmaceutically acceptable vehicle and a thickening agent. The present invention further provides a method of treating patients in need of prednisolone with the novel formulation.
摘要翻译：本发明涉及包含醋酸泼尼松龙，药学上可接受的载体和增稠剂的新型口服悬浮液制剂。本发明还提供了一种用新型制剂治疗需要泼尼松龙的患者的方法。

10. 发明申请

US20090023638A1 SPILL RESISTANT ANTIBIOTIC FORMULATIONS 审中-公开
标题翻译：防发抗生素制剂
公开(公告)号：US20090023638A1
公开(公告)日：2009-01-22
申请号：US12162675
申请日：2007-02-02
申请人： Satish Asotra , Shen Gao
发明人： Satish Asotra , Shen Gao
IPC分类号： A61K38/14 , A61K31/43 , A61K31/546 , A61K31/7052 , A61K31/7048
CPC分类号： A61K9/0095 , A61K47/10 , A61K47/26 , A61K47/32
摘要： The disclosure is directed to a pharmaceutical kit with a first set, a second set and a third set of components. The first set of components can be a carbomer in an aqueous vehicle, the second set of components can be an antibiotic, and the third set of components can be a neutralizing agent. In exemplary embodiments, the first, second and third sets of components can be mixed together to form a spill resistant composition.
摘要翻译：本公开涉及具有第一组，第二组和第三组成分的药物试剂盒。第一组成分可以是水性载体中的卡波姆，第二组成分可以是抗生素，第三组成分可以是中和剂。在示例性实施例中，第一组，第二组和第三组组件可以混合在一起以形成防溢出组合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式